<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Channels &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/channels/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>ACE inhibitor treated hypertension linked to reduced all-cause mortality</title>
		<link>http://www.thedoctorschannel.com/view/ace-inhibitor-treated-hypertension-linked-to-reduced-all-cause-mortality/</link>
		<pubDate>Wed, 16 May 2012 15:39:22 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Home Page Featured]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[ACE inhibitor]]></category>
		<category><![CDATA[angiotensin]]></category>
		<category><![CDATA[hypertension]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31830</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include an ACE inhibitor, according to the results of a meta-analysis reported in the European Heart Journal online April 17. “In view of the high prevalence of hypertension -]]></description>
		
			<media:content duration="1:23" medium="video">
		<media:title><![CDATA[ACE inhibitor treated hypertension linked to reduced all-cause mortality]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – All-cause mortality rates among hypertensive patients treated with an angiotensin-converting enzyme inhibitor are 10% lower than in those whose treatment does not include an ACE inhibitor, according to the results of a meta-analysis reported in the European Heart Journal online April 17. “In view of the high prevalence of hypertension -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/ace-inhibitor-treated-hypertension-linked-to-reduced-all-cause-mortality/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120516epid004.jpg"/>
	<media:keywords><![CDATA[ACE inhibitor,angiotensin,hypertension]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Comprehensive care program does not prevent COPD hospitalizations</title>
		<link>http://www.thedoctorschannel.com/view/comprehensive-care-program-does-not-prevent-copd-hospitalizations/</link>
		<pubDate>Wed, 16 May 2012 15:30:24 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Home Page Featured]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pulmonary Medicine]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[SHM 2011 Conference Coverage]]></category>
		<category><![CDATA[COPD]]></category>
		<category><![CDATA[education]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31828</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – A program of patient education and planning aimed at treating exacerbations of chronic obstructive pulmonary disease early and reducing rates of hospitalization was not effective in a randomized controlled trial. In fact, the trial was stopped when it was seen that the intervention was associated with a threefold increase in -]]></description>
		
			<media:content duration="1:38" medium="video">
		<media:title><![CDATA[Comprehensive care program does not prevent COPD hospitalizations]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – A program of patient education and planning aimed at treating exacerbations of chronic obstructive pulmonary disease early and reducing rates of hospitalization was not effective in a randomized controlled trial. In fact, the trial was stopped when it was seen that the intervention was associated with a threefold increase in -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/comprehensive-care-program-does-not-prevent-copd-hospitalizations/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120516clin002.jpg"/>
	<media:keywords><![CDATA[COPD,education]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Sumatriptan-naproxen combo effective for adolescent migraine</title>
		<link>http://www.thedoctorschannel.com/view/sumatriptan-naproxen-combo-effective-for-adolescent-migraine/</link>
		<pubDate>Wed, 16 May 2012 15:16:39 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Home Page Featured]]></category>
		<category><![CDATA[Neurology & Neurosurgery]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[migraine]]></category>
		<category><![CDATA[naproxen]]></category>
		<category><![CDATA[sumatriptan]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31826</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Based on the results of a randomized, double-blind trial, more adolescents with acute migraine become pain-free within 2 hours after taking a combination of sumatriptan and naproxen sodium compared to placebo, according to a report in the June issue of Pediatrics. “This study constitutes the first large-scale, placebo-controlled evidence for -]]></description>
		
			<media:content duration="1:30" medium="video">
		<media:title><![CDATA[Sumatriptan-naproxen combo effective for adolescent migraine]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Based on the results of a randomized, double-blind trial, more adolescents with acute migraine become pain-free within 2 hours after taking a combination of sumatriptan and naproxen sodium compared to placebo, according to a report in the June issue of Pediatrics. “This study constitutes the first large-scale, placebo-controlled evidence for -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/sumatriptan-naproxen-combo-effective-for-adolescent-migraine/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120516clin001.jpg"/>
	<media:keywords><![CDATA[migraine,naproxen,sumatriptan]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Aspirin use doesn&#8217;t curb peptic ulcer healing</title>
		<link>http://www.thedoctorschannel.com/view/aspirin-use-doesnt-curb-peptic-ulcer-healing/</link>
		<pubDate>Tue, 15 May 2012 18:56:57 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Hospitalist]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[aspirin]]></category>
		<category><![CDATA[esomeprazole]]></category>
		<category><![CDATA[peptic ulcer]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31795</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; In patients with aspirin-related peptic ulcers, ulcer healing rates are comparable after esomeprazole therapy with or without aspirin continuation, Taiwanese researchers report in an April 17th on-line paper in The American Journal of Gastroenterology. In fact, the investigators suggest that &#8220;continuing low-dose aspirin plus a proton pump inhibitor is the -]]></description>
		
			<media:content duration="1:34" medium="video">
		<media:title><![CDATA[Aspirin use doesn&#8217;t curb peptic ulcer healing]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; In patients with aspirin-related peptic ulcers, ulcer healing rates are comparable after esomeprazole therapy with or without aspirin continuation, Taiwanese researchers report in an April 17th on-line paper in The American Journal of Gastroenterology. In fact, the investigators suggest that &#8220;continuing low-dose aspirin plus a proton pump inhibitor is the -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/aspirin-use-doesnt-curb-peptic-ulcer-healing/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120515clin005.jpg"/>
	<media:keywords><![CDATA[aspirin,esomeprazole,peptic ulcer]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>ACE inhibitors tied to increased angioedema risk</title>
		<link>http://www.thedoctorschannel.com/view/ace-inhibitors-tied-to-increased-angioedema-risk/</link>
		<pubDate>Tue, 15 May 2012 18:53:02 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nephrology]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[ACE inhibitors]]></category>
		<category><![CDATA[angioedema]]></category>
		<category><![CDATA[angiotensin]]></category>
		<category><![CDATA[ARB]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31793</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Pooled data suggest that use of renin–angiotensin system (RAS) inhibitors, particularly angiotensin converting enzyme (ACE) inhibitors may increase the risk of angioedema, researchers report in an April 20th on-line paper in the American Journal of Cardiology. Nevertheless, Dr. Franz H. Messerli told Reuters Health by email, &#8220;ACE inhibitors are among -]]></description>
		
			<media:content duration="1:29" medium="video">
		<media:title><![CDATA[ACE inhibitors tied to increased angioedema risk]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Pooled data suggest that use of renin–angiotensin system (RAS) inhibitors, particularly angiotensin converting enzyme (ACE) inhibitors may increase the risk of angioedema, researchers report in an April 20th on-line paper in the American Journal of Cardiology. Nevertheless, Dr. Franz H. Messerli told Reuters Health by email, &#8220;ACE inhibitors are among -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/ace-inhibitors-tied-to-increased-angioedema-risk/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120515clinc003.jpg"/>
	<media:keywords><![CDATA[ACE inhibitors,angioedema,angiotensin,ARB]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Hand surgery helpful for RA associated deformities</title>
		<link>http://www.thedoctorschannel.com/view/hand-surgery-helpful-for-ra-associated-deformities/</link>
		<pubDate>Tue, 15 May 2012 18:48:10 +0000</pubDate> 
				<category><![CDATA[Orthopedics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Rheumatology]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[hand surgery]]></category>
		<category><![CDATA[rheumatoid arthritis]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31791</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Both hand function and appearance are improved in rheumatoid arthritis (RA) patients with severe deformities treated by silicone metacarpophalangeal joint arthroplasty (SMPA), researchers report in an April 17th on-line paper in Arthritis Care &#038; Research. Dr. Kevin C. Chung and colleagues at The University of Michigan Health System, Ann Arbor -]]></description>
		
			<media:content duration="1:32" medium="video">
		<media:title><![CDATA[Hand surgery helpful for RA associated deformities]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Both hand function and appearance are improved in rheumatoid arthritis (RA) patients with severe deformities treated by silicone metacarpophalangeal joint arthroplasty (SMPA), researchers report in an April 17th on-line paper in Arthritis Care &#038; Research. Dr. Kevin C. Chung and colleagues at The University of Michigan Health System, Ann Arbor -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/hand-surgery-helpful-for-ra-associated-deformities/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120515clin004.jpg"/>
	<media:keywords><![CDATA[hand surgery,rheumatoid arthritis]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Good long-term survival after catheter valvotomy for pulmonary atresia</title>
		<link>http://www.thedoctorschannel.com/view/good-long-term-survival-after-catheter-valvotomy-for-pulmonary-atresia/</link>
		<pubDate>Mon, 14 May 2012 17:19:50 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[catheter valvotomy]]></category>
		<category><![CDATA[Pulmonary atresia]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31748</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Catheter valve perforation for pulmonary atresia with intact ventricular septum (PAIVS) offers good long-term survival with few complications, according to findings published in the April 17th Journal of the American College of Cardiology. PAIVS occurs in 3 to 8 of 100,000 births, and catheter perforation is now an established procedure -]]></description>
		
			<media:content duration="1:37" medium="video">
		<media:title><![CDATA[Good long-term survival after catheter valvotomy for pulmonary atresia]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Catheter valve perforation for pulmonary atresia with intact ventricular septum (PAIVS) offers good long-term survival with few complications, according to findings published in the April 17th Journal of the American College of Cardiology. PAIVS occurs in 3 to 8 of 100,000 births, and catheter perforation is now an established procedure -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/good-long-term-survival-after-catheter-valvotomy-for-pulmonary-atresia/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120514drgd002.jpg"/>
	<media:keywords><![CDATA[catheter valvotomy,Pulmonary atresia]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Mefloquine malaria prophylaxis appears safe during pregnancy</title>
		<link>http://www.thedoctorschannel.com/view/mefloquine-malaria-prophylaxis-appears-safe-during-pregnancy-2/</link>
		<pubDate>Mon, 14 May 2012 17:09:43 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Travel Medicine]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[Mefloquine]]></category>
		<category><![CDATA[pregnancy]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31746</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Pregnant women may safely receive mefloquine for malaria prophylaxis, researchers from Switzerland report in the April 10th online Clinical Infectious Diseases. “Women who inadvertently become pregnant while taking mefloquine should be reassured that the risk of malformations is low (within background levels) and that use of mefloquine does not indicate -]]></description>
		
			<media:content duration="1:47" medium="video">
		<media:title><![CDATA[Mefloquine malaria prophylaxis appears safe during pregnancy]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Pregnant women may safely receive mefloquine for malaria prophylaxis, researchers from Switzerland report in the April 10th online Clinical Infectious Diseases. “Women who inadvertently become pregnant while taking mefloquine should be reassured that the risk of malformations is low (within background levels) and that use of mefloquine does not indicate -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/mefloquine-malaria-prophylaxis-appears-safe-during-pregnancy-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120514epid0011.jpg"/>
	<media:keywords><![CDATA[malaria,Mefloquine,pregnancy]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Noninvasive programmed stimulation predicts recurrence of ventricular tachycardia</title>
		<link>http://www.thedoctorschannel.com/view/noninvasive-programmed-stimulation-predicts-recurrence-of-ventricular-tachycardia/</link>
		<pubDate>Mon, 14 May 2012 16:24:41 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[NIPS]]></category>
		<category><![CDATA[Noninvasive programmed stimulation]]></category>
		<category><![CDATA[VT ablation]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31744</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Noninvasive programmed stimulation (NIPS) days after ventricular tachycardia (VT) ablation can predict the risk of recurrence, according to findings published in the April 24th Journal of the American College of Cardiology. “The recurrence rate following VT ablation in structural heart disease remains substantial and thus better endpoints for VT ablation -]]></description>
		
			<media:content duration="1:50" medium="video">
		<media:title><![CDATA[Noninvasive programmed stimulation predicts recurrence of ventricular tachycardia]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Noninvasive programmed stimulation (NIPS) days after ventricular tachycardia (VT) ablation can predict the risk of recurrence, according to findings published in the April 24th Journal of the American College of Cardiology. “The recurrence rate following VT ablation in structural heart disease remains substantial and thus better endpoints for VT ablation -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/noninvasive-programmed-stimulation-predicts-recurrence-of-ventricular-tachycardia/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120514drgd001.jpg"/>
	<media:keywords><![CDATA[NIPS,Noninvasive programmed stimulation,VT ablation]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Skin prick test tied to cow&#8217;s milk allergy persistence</title>
		<link>http://www.thedoctorschannel.com/view/skin-prick-test-tied-to-cows-milk-allergy-persistence/</link>
		<pubDate>Fri, 11 May 2012 21:03:38 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[allergy]]></category>
		<category><![CDATA[Cow's milk]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31703</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Skin prick testing results and early reactions are among indicators of the course of IgE-mediated cow’s milk allergy (CMA) in infants, Israeli researchers report in an April 4th on-line paper in the Journal of Pediatrics. &#8220;The main finding of this study,&#8221; Dr. Arnon Elizur told Reuters Health by email, &#8220;is -]]></description>
		
			<media:content duration="1:41" medium="video">
		<media:title><![CDATA[Skin prick test tied to cow&#8217;s milk allergy persistence]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Skin prick testing results and early reactions are among indicators of the course of IgE-mediated cow’s milk allergy (CMA) in infants, Israeli researchers report in an April 4th on-line paper in the Journal of Pediatrics. &#8220;The main finding of this study,&#8221; Dr. Arnon Elizur told Reuters Health by email, &#8220;is -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/skin-prick-test-tied-to-cows-milk-allergy-persistence/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120511epid008.jpg"/>
	<media:keywords><![CDATA[allergy,Cow's milk]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
